Clinical Trials
225 trialsEvaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
University of Kentucky
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
IMPACT
Medical University of South Carolina
OPTIVISMO-1
University Hospital, Bordeaux
Evolut™ EXPAND TAVR II Pivotal Trial
Medtronic Cardiovascular
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Fudan University
BActinium-1
Aktis Oncology, Inc.
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
University of Alberta
SNIFF
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RESPONd
University of Calgary
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
First Affiliated Hospital of Guangxi Medical University
SOAR
University of Toronto
CHALLENGE
Canadian Cancer Trials Group
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Aktis Oncology, Inc.
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Emory University
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
Hangzhou Cancer Hospital
STOP-CLL-DCT
UNC Lineberger Comprehensive Cancer Center
CARES-Lite
University of Pittsburgh
PBM-LEF
NYU Langone Health
STEPS-BC
Wake Forest University Health Sciences
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
OHSU Knight Cancer Institute
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
INSPIRE
Medical University of South Carolina
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis
Cairo University
FOCALE
Hospices Civils de Lyon
Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection
Tanta University
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma
Qingdao Sino-Cell Biomedicine Co., Ltd.
Niraparib In Recurrent IDH 1/2 Gliomas
Massachusetts General Hospital
Cervical Thermal Ablation to Treat Persistent HPV Infection
Hvidovre University Hospital
A-319
Shanxi Bethune Hospital
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
Sun Yat-sen University
Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.
Peking University Third Hospital
CRANIO4US
Universität Duisburg-Essen
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Georgetown University
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
University of California, San Francisco
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
University of Chicago
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Georgetown University
Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)
Universitätsklinikum Hamburg-Eppendorf
Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
Changhai Hospital
EXHITENTRE
Hennepin Healthcare Research Institute
OptiTri_MT
Institut de Recherche pour le Developpement
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Thomas Jefferson University
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Building Connections
Massachusetts General Hospital
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
PRONTO-HN
Centre hospitalier de l'Université de Montréal (CHUM)
Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors
Yale University
EXACT-1
Aresus Pharma GmbH